Updated July 2026 · 7 min read

Octreotide: The ICU Nurse's Guide

Part of the ICU Emergencies Hub — browse every related guide in one place.

When a cirrhotic patient arrives vomiting blood, octreotide is one of the first drips you'll hang. It's a synthetic version of the hormone somatostatin, and its job in the bleeding patient is to turn down the pressure in the portal system so the varices have a chance to stop. It won't fix the bleed alone, but it buys the time endoscopy needs.

How octreotide works

Octreotide is a long-acting somatostatin analog. In the gut, it constricts the splanchnic (mesenteric) circulation, reducing blood flow into the portal system and therefore lowering portal venous pressure. Less pressure in the portal system means less pressure driving blood out of ruptured esophageal or gastric varices, giving clot and endoscopic therapy a chance to hold. It also suppresses a range of GI hormones and secretions.

Variceal and upper GI bleeding

In suspected variceal hemorrhage, octreotide is typically started early — often before endoscopy confirms the source — because the sooner portal pressure drops, the better. A common regimen is a bolus of about 50 mcg IV followed by a continuous infusion of roughly 50 mcg/hour, continued for a few days after the bleed is controlled. It's frequently used empirically in any significant upper GI bleed in a patient who might have varices, then continued or stopped once the source is known.

The bleed bundle around octreotide

Octreotide rarely works alone. The nursing picture around a variceal bleed includes large-bore access and blood product resuscitation, a careful watch on the airway (these patients aspirate), prophylactic antibiotics (which improve outcomes in cirrhotic GI bleeds), and coordination for urgent endoscopy. Octreotide is the pharmacologic bridge that holds the line while the team assembles the definitive fix.

Sulfonylurea-induced hypoglycemia

Octreotide has a second, very different job: it treats persistent hypoglycemia from a sulfonylurea overdose. Sulfonylureas force insulin release; giving dextrose alone can paradoxically trigger even more insulin and a rebound low. Octreotide suppresses that insulin secretion, breaking the cycle and stabilizing the glucose. In this setting it's a targeted antidote rather than a bleed drug.

The monitoring that matters

In the actively bleeding patient, remember that octreotide's benefit is invisible on the monitor — you're tracking the bleed itself (output, hemoglobin trend, hemodynamics) and the resuscitation, with octreotide running quietly in the background to reduce portal pressure.

Bottom line

Octreotide is the go-to drip for variceal and upper GI bleeding, lowering portal pressure to slow the hemorrhage while resuscitation, antibiotics, and endoscopy do the definitive work. Start it early, run the bolus-then-infusion, and treat it as one part of a coordinated bundle. Keep an eye on glucose and heart rate, and remember its second life as the antidote for stubborn sulfonylurea hypoglycemia. It's an unglamorous drug that quietly saves cirrhotic patients every day.

This article is general educational information for licensed clinicians and students, not medical advice or a substitute for your institution's protocols, pharmacy guidance, or a provider's orders. Always follow facility policy and verify doses independently.